Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity

被引:19
作者
Agha, A
Opekun, AR
Abudayyeh, S
Graham, DY
机构
[1] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1111/j.1365-2036.2005.02440.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The mechanism of citric acid-enhanced Helicobacter pylori urease activity remains unclear. Aim: To compare ascorbic, citric and malic acid given at the same concentration and pH on intragastric urease activity. Methods: Volunteers received 40 mg of famotidine the evening prior to breath testing. After an overnight fast volunteers were randomized to receive 100 mL of water or 100 m<smallcapitals>m</smallcapitals> citric, malic, or ascorbic acid, pH 2.3 containing 75 mg of C-13-urea. At 15 min a second 100 mL solution of one of the test solutions was taken without added urea. Results: Twelve volunteers were studied (eight men, four women, age 19-57, median 50.7) in a randomized-crossover study. The mean breath test result at 30 min with ascorbic (17.5 +/- 5), malic (25.8 +/- 5) and citric acid (29.5 +/- 5) were all significantly greater than with water (9.5 +/- 3). Citric and malic acid were similar (P = 0.699) and significantly greater than ascorbic acid (P < 0.02). When the ascorbic acid was followed by citric acid, the result was similar to that with citrate alone (25.8 +/- 4) and greater than with ascorbic then ascorbic (P = 0.026). Conclusions: Enhancement of H. pylori urease activity is not strictly a function of the pH. We propose the effect is related to differential effects of the availability of nickel, which is required for urease activity. Citric acid and malic acid were essentially equivalent such that malic acid could substitute for citric acid in the UBT; ascorbic acid would be a poor choice.
引用
收藏
页码:1145 / 1148
页数:4
相关论文
共 29 条
[1]  
Axon A, 1996, HELICOBACTER PYLORI, P269
[2]   Dependence of Helicobacter pylori urease activity on the nickel-sequestering ability of the UreE accessory protein [J].
Benoit, S ;
Maier, RJ .
JOURNAL OF BACTERIOLOGY, 2003, 185 (16) :4787-4795
[3]  
EGGERS RH, 1990, EUR J GASTROEN HEPAT, V2, P437
[4]   CHARACTERIZATION OF THE HELICOBACTER-PYLORI UREASE AND PURIFICATION OF ITS SUBUNITS [J].
EVANS, DJ ;
EVANS, DG ;
KIRKPATRICK, SS ;
GRAHAM, DY .
MICROBIAL PATHOGENESIS, 1991, 10 (01) :15-26
[5]  
Fujioka T, 1993, Nihon Rinsho, V51, P3255
[6]   A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment [J].
Gatta, L ;
Vakil, N ;
Ricci, C ;
Osborn, JF ;
Tampieri, A ;
Perna, F ;
Miglioli, M ;
Vaira, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (06) :793-798
[7]   THE MINIMUM INHIBITORY AND BACTERICIDAL CONCENTRATIONS OF ANTIBIOTICS AND ANTIULCER AGENTS AGAINST CAMPYLOBACTER-PYLORIDIS [J].
GOODWIN, CS ;
BLAKE, P ;
BLINCOW, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :309-314
[8]   False negative urea breath tests with H2-receptor antagonists:: Interactions between Helicobacter pylori density and pH [J].
Graham, DY ;
Opekun, AR ;
Jogi, M ;
Yamaoka, Y ;
Lu, H ;
Reddy, R ;
Ei-Zimaity, HMT .
HELICOBACTER, 2004, 9 (01) :17-27
[9]  
GRAHAM DY, 1989, AM J GASTROENTEROL, V84, P233
[10]  
Graham DY, 1999, AM J GASTROENTEROL, V94, P1214, DOI 10.1111/j.1572-0241.1999.01069.x